SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-18-000027
Filing Date
2018-05-08
Accepted
2018-05-08 16:38:33
Documents
85
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20180331x10q.htm 10-Q 1785494
2 EX-10.1 kdmn-20180331xex10_1.htm EX-10.1 261129
3 EX-31.1 kdmn-20180331xex31_1.htm EX-31.1 19928
4 EX-31.2 kdmn-20180331xex31_2.htm EX-31.2 19949
5 EX-32.1 kdmn-20180331xex32_1.htm EX-32.1 10188
6 EX-32.2 kdmn-20180331xex32_2.htm EX-32.2 10044
  Complete submission text file 0001557142-18-000027.txt   8367150

Data Files

Seq Description Document Type Size
7 EX-101.INS kdmn-20180331.xml EX-101.INS 1858286
8 EX-101.SCH kdmn-20180331.xsd EX-101.SCH 53373
9 EX-101.CAL kdmn-20180331_cal.xml EX-101.CAL 68190
10 EX-101.DEF kdmn-20180331_def.xml EX-101.DEF 272239
11 EX-101.LAB kdmn-20180331_lab.xml EX-101.LAB 403184
12 EX-101.PRE kdmn-20180331_pre.xml EX-101.PRE 433151
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 18815250
SIC: 2834 Pharmaceutical Preparations